02.03.2018
Over it’s ten year’s history, the Berlin Conference has become a must-attend event for Life Science decision makers, business developers, investors and legal experts.
The 11th conference will explore the exciting market for the development of novel antimicrobials and AMR diagnostics.
Antimicrobial Market – Industry overview, SME engagement & financial insights
Technology Perspective – New approaches to efficiently combat antimicrobial resistance
Diagnostic Challenge – Promising molecular methods of detecting multiple drug resistance
Legal Environment & Reimbursement – The challenges of bringing antimicrobials to the market
R&D Trends – Research and development beyond antibiotics & public-private partnerships
Start-up Pitch – Investor talk & new business models in the field of therapeutics and diagnostics
https://european-biotechnology.com/events/highlights/highlight/11th-berlin-conference-on-life-sciences-novel-antimicrobials-and-amr-diagnostics.html